Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtable

This publication has 53 references indexed in Scilit:

• Important aspects of T‐cell collection by apheresis for manufacturing chimeric antigen receptor T cells
  Advances in Cell and Gene Therapy, 2019
• T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma
  Blood Advances, 2019
• The Challenge of Variability in Chimeric Antigen Receptor T Cell Manufacturing
  Regenerative Engineering and Translational Medicine, 2019
• ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
  Transplantation and Cellular Therapy, 2019
• Management of ‘out of specification’ commercial autologous CAR-T cell products
  Cell & Gene Therapy Insights, 2018
• A guide to manufacturing CAR T cell therapies
  Current Opinion in Biotechnology, 2018
• Building a CAR Garage: Preparing for the Delivery of Commercial CAR T Cell Products at Memorial Sloan Kettering Cancer Center
  Transplantation and Cellular Therapy, 2018
• The why, what, and how of the new FACT standards for immune effector cells
  Journal for ImmunoTherapy of Cancer, 2017
• A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma
  Cancer, 2015
• B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
  Clinical Cancer Research, 2013